Summary
Microbial constituents naturally inhabiting the gastrointestinal tract may influence the homeostasis of the gut environment. The presence or overabundance of some bacterial taxa has been reported to be associated with complex diseases, and the metabolites of certain bacteria may contribute to diverse disorders by influencing signaling pathways. Therefore, the study of gut microbial population has emerged as a crucial field and a new potential area of clinical significance. Advances in the methods of microbiota analysis have shed light upon the details including species diversity, microfloral activities as well as the entire gut microbiota. Nevertheless, comprehensive reviews on this subject are still limited. For elucidating the appropriate selection strategy of the methods to address a particular research question, we comprehensively reviewed the continuously improving technologies, classical to newly developed, and dissected their relative advantages and drawbacks. In addition, aiming at the rapidly advancing next-generation sequencing, we enumerated the improvements in mainstream platforms and made the horizontal and vertical comparison among them. Additionally, we demonstrated the four main -omics methods, which may provide further mechanistic insights into the role of microbiota, to propel phylotyping analysis to functional analysis.
Similar content being viewed by others
References
Steinhoff U. Who controls the crowd? New findings and old questions about the intestinal microflora. Immunol Lett, 2005,99(1):12–16
Human Microbiome ProjectC. A framework for human microbiome research. Nature, 2012,486(7402):215–221
Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature, 2012,486(7402):207–214
Keates-Baleeiro J, Moore P, Koyama T, et al. Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients. Bone Marrow Transplant, 2006,38(4):285–289
Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol, 2013,11(4):227–238
Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell, 2012,148(6):1258–1270
Khanna S, Tosh PK. A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clin Proc, 2014,89(1):107–114
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet, 2003,361(9356):512–519
Dinan TG, Cryan JF. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care, 2015,18(6):552–558
Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012,490(7418):55–60
Perry RJ, Peng L, Barry NA, et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature, 2016,534(7606):213–217
Boulange CL, Neves AL, Chilloux J, et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med, 2016,8(1):42
Gerritsen J, Smidt H, Rijkers GT, et al. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr, 2011,6(3):209–240
Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell, 2013,155(7):1451–1463
Hill JM, Bhattacharjee S, Pogue AI, et al. The gastrointestinal tract microbiome and potential link to Alzheimer’s disease. Front Neurol, 2014,5:43
Fraher MH, O’Toole PW and Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol, 2012,9(6):312–322
Kuczynski J, Lauber CL, Walters WA, et al. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet, 2012,13(1):47–58
Maron PA, Ranjard L, Mougel C, et al. Metaproteomics: a new approach for studying functional microbial ecology. Microb Ecol, 2007,53(3):486–493
Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature, 2009,457(7228):480–484
Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr, 1974,27(12):1456–1469
Gossling J, Slack JM. Predominant gram-positive bacteria in human feces: numbers, variety, and persistence. Infect Immun, 1974,9(4):719–729
Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol, 1974,27(5):961–979
Zengler K, Toledo G, Rappe M, et al. Cultivating the uncultured. Proc Natl Acad Sci USA, 2002,99(24): 15681–15686
Zengler K, Walcher M, Clark G, et al. High-throughput cultivation of microorganisms using microcapsules. Methods Enzymol, 2005,397:124–130
Bollmann A, Lewis K, Epstein SS. Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates. Appl Environ Microbiol, 2007,73(20):6386–6390
Kaeberlein T, Lewis K, Epstein SS. Isolating “uncultivable” microorganisms in pure culture in a simulated natural environment. Science, 2002,296(5570):1127–1129
Ingham CJ, Sprenkels A, Bomer J, et al. The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganisms. Proc Natl Acad Sci USA, 2007,104(46):18217–18222
McDonald JA, Schroeter K, Fuentes S, et al. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J Microbiol Methods, 2013,95(2):167–174
Ma L, Kim J, Hatzenpichler R, et al. Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project’s Most Wanted taxa. Proc Natl Acad Sci USA, 2014,111(27):9768–9773
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science, 2005,308(5728):1635–1638
Lagier JC, Armougom F, Million M, et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect, 2012,18(12):1185–1193
Lau JT, Whelan FJ, Herath I, et al. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome Med, 2016,8(1):72
Lagier JC, Million M, Hugon P, et al. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol, 2012,2:136
Clarridge JE, 3rd. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev, 2004,17(4):840–862, table of contents
Kolbert CP, Persing DH. Ribosomal DNA sequencing as a tool for identification of bacterial pathogens. Curr Opin Microbiol, 1999,2(3):299–305
Lu T, Stroot PG, Oerther DB. Reverse transcription of 16S rRNA to monitor ribosome-synthesizing bacterial populations in the environment. Appl Environ Microbiol, 2009,75(13):4589–4598
Olsen GJ, Lane DJ, Giovannoni SJ, et al. Microbial ecology and evolution: a ribosomal RNA approach. Annu Rev Microbiol, 1986,40:337–365
von Wintzingerode F, Gobel UB, Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev, 1997,21(3):213–229
Kieler IN, Molbak L, Hansen LL, et al. Overweight and the feline gut microbiome -a pilot study. J Anim Physiol Anim Nutr (Berl), 2016,100(3):478–484
Radilla-Vazquez RB, Parra-Rojas I, Martinez-Hernandez NE, et al. Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects. Obes Facts, 2016,9(1):1–11
Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut, 2013,62(4):531–539
Ponnusamy K, Choi JN, Kim J, et al. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol, 2011, 60(Pt 6):817–827
Obermajer T, Lipoglavsek L, Tompa G, et al. Colostrum of healthy Slovenian mothers: microbiota composition and bacteriocin gene prevalence. PLoS One, 2014, 10(4): e0123324
Riddle MS and Connor BA. The Traveling Microbiome. Curr Infect Dis Rep, 2016,18(9):29
Fischer SG, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA, 1983,80(6):1579–1583
Ramnani P, Costabile A, Bustillo AG, et al. Arandomised, double-blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. J Nutr Sci, 2015, 4:e10
Fischer SG, Lerman LS. Separation of random fragments of DNA according to properties of their sequences. Proc Natl Acad Sci USA, 1980,77(8):4420–4424
Liu WT, Marsh TL, Cheng H, et al. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol, 1997,63(11):4516–4522
Dave M, Johnson LA, Walk ST, et al. A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum. Gut, 2011,60(8):1043–1049
Brooks JP, Edwards DJ, Harwich MD, Jr., et al. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol, 2015,15:66
Hayashi H, Sakamoto M, Kitahara M, et al. Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol Immunol, 2003,47(8):557–570
Matsumoto M, Sakamoto M, Hayashi H, et al. Novel phylogenetic assignment database for terminalrestriction fragment length polymorphism analysis of human colonic microbiota. J Microbiol Methods, 2005,61(3):305–319
Mark Welch JL, Rossetti BJ, Rieken CW, et al. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci USA, 2016, 113(6):E791–800
Smith PA. The tantalizing links between gut microbes and the brain. Nature, 2015,526(7573):312–314
Ingber DE. Reverse Engineering Human Pathophysiology with Organs-on-Chips. Cell, 2016,164(6):1105–1109
Dewulf EM, Cani PD, Claus SP, et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut, 2013,62(8):1112–1121
Michail S, Durbin M, Turner D, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis, 2012,18(10):1799–1808
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA, 1977,74(12):5463–5467
Collins FS, Morgan M and Patrinos A. The Human Genome Project: lessons from large-scale biology. Science, 2003,300(5617):286–290
Hall N. Advanced sequencing technologies and their wider impact in microbiology. J Exp Biol, 2007, 210(Pt 9):1518–1525
de Magalhaes JP, Finch CE, Janssens G. Next-generation sequencing in aging research: emerging applications, problems, pitfalls and possible solutions. Ageing Res Rev, 2010,9(3):315–323
Jeffery IB, O’Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut, 2012,61(7):997–1006
Tang J, Iliev ID, Brown J, et al. Mycobiome: Approaches to analysis of intestinal fungi. J Immunol Methods, 2015,421:112–121
Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet, 2016,17(6):333–351
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature, 2012,486(7402):222–227
Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut, 2015,64(5):731–742
Olivares M, Neef A, Castillejo G, et al. The HLADQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut, 2015,64(3):406–417
Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 2010,5(2):e9085
Andersson AF, Lindberg M, Jakobsson H, et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One, 2008,3(7):e2836
Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA, 2010,107(16):7503–7508
P OC, Aguirre de Carcer D, Jones M, et al. The effects from DNA extraction methods on the evaluation of microbial diversity associated with human colonic tissue. Microb Ecol, 2011,61(2):353–362
Yuan S, Cohen DB, Ravel J, et al. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One, 2012,7(3):e33865
Gilles A, Meglecz E, Pech N, et al. Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing. BMC Genomics, 2011,12:245
Luo C, Tsementzi D, Kyrpides N, et al. Direct comparisons of Illumina vs. Roche 454 sequencing technologies on the same microbial community DNA sample. PLoS One, 2012,7(2):e30087
Konstantinidis KT, Tiedje JM. Prokaryotic taxonomy and phylogeny in the genomic era: advancements and challenges ahead. Curr Opin Microbiol, 2007,10(5):504–509
Sanschagrin S, Yergeau E. Next-generation sequencing of 16S ribosomal RNA gene amplicons. J Vis Exp, 2014(90). doi:10.3791/51709
Lagier JC, Hugon P, Khelaifia S, et al. The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev, 2015,28(1):237–264
Xiong W, Abraham PE, Li Z, et al. Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota. Proteomics, 2015,15(20):3424–3438
Reigstad CS, Kashyap PC. Beyond phylotyping: understanding the impact of gut microbiota on host biology. Neurogastroenterol Motil, 2013,25(5):358–372
Wang WL, Xu SY, Ren ZG, et al. Application of metagenomics in the human gut microbiome. World J Gastroenterol, 2015,21(3):803–814
Staden R. A strategy of DNA sequencing employing computer programs. Nucleic Acids Res, 1979,6(7):2601–2610
Poinar HN, Schwarz C, Qi J, et al. Metagenomics to paleogenomics: large-scale sequencing of mammoth DNA. Science, 2006,311(5759):392–394
Metzker ML. Sequencing technologies -the next generation. Nat Rev Genet, 2010,11(1):31–46
Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev, 2010,90(3):859–904
Ranjan R, Rani A, Metwally A, et al. Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun, 2016,469(4):967–977
De Vos WM. Mining the microbes—the human microbiome as model. Microb Biotechnol, 2009,2(2): 153–154
Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013,498(7452):99–103
Karlsson FH, Fak F, Nookaew I, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 2012,3:1245
Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med, 2015,21(8):895–905
Ma J, Prince A, Aagaard KM. Use of whole genome shotgun metagenomics: a practical guide for the microbiome-minded physician scientist. Semin Reprod Med, 2014,32(1):5–13
Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet, 2009,10(1):57–63
Westermann AJ, Gorski SA, Vogel J. Dual RNA-seq of pathogen and host. Nat Rev Microbiol, 2012,10(9):618–630
Bashiardes S, Zilberman-Schapira G, Elinav E. Use of Metatranscriptomics in Microbiome Research. Bioinform Biol Insights, 2016,10:19–25
Franzosa EA, Morgan XC, Segata N, et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci USA, 2014, 111(22):E2329–2338
Gosalbes MJ, Durban A, Pignatelli M, et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS One, 2011,6(3):e17447
Peano C, Pietrelli A, Consolandi C, et al. An efficient rRNA removal method for RNA sequencing in GC-rich bacteria. Microb Inform Exp, 2013,3(1):1
Simon C, Daniel R. Metagenomic analyses: past and future trends. Appl Environ Microbiol, 2011,77(4):1153–1161
Alves P, Arnold RJ, Novotny MV, et al. Advancement in protein inference from shotgun proteomics using peptide detectability. Pac Symp Biocomput, 2007:409–420
Hu L, Ye M, Jiang X, et al. Advances in hyphenated analytical techniques for shotgun proteome and peptidome analysis—a review. Anal Chim Acta, 2007,598(2):193–204
Jordan KW, Nordenstam J, Lauwers GY, et al. Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum, 2009,52(3):520–525
Aldridge BB, Rhee KY. Microbial metabolomics: innovation, application, insight. Curr Opin Microbiol, 2014,19:90–96
Vernocchi P, Del Chierico F, Putignani L. Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol, 2016,7:1144
Aguiar-Pulido V, Huang W, Suarez-Ulloa V, et al. Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis. Evol Bioinform Online, 2016, 12(Suppl 1):5–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feng, Xw., Ding, Wp., Xiong, Ly. et al. Recent Advancements in Intestinal Microbiota Analyses: A Review for Non-Microbiologists. CURR MED SCI 38, 949–961 (2018). https://doi.org/10.1007/s11596-018-1969-z
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-018-1969-z